XBiotech Inc
€2.062
EUR
Last updated on --.
24h volume19.09K
24h highest2.1300 EUR
24h lowest2.0672 EUR
24h Price movement-1.23%
XBIT recent prices
24 Hours
-1.23%-€0.025776
30 days
-6.80%-€0.15036
60 days
+7.49%+€0.14606
90 days
+2.13%+€0.04296
Key data
Previous close2.0879 EUR
Market cap62.61M EUR
Volume19.09K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount1.8039 EUR
Next ex-dividend dateJul 15, 2021
Next payment dateJul 23, 2021
EPS diluted (TTM)-1.1341 EUR
Net income (FY)-34.51M EUR
Revenue (FY)--
Last report dateMay 14, 2026
About XBiotech Inc
HeadquartersAUSTIN
Employees (FY)87.00
Net income per employee (FY)-396.62K EUR
Listed onNasdaq
XBIT conversion tables
 |  |
|---|---|
| 0.5 XBIT | 1.031 EUR |
| 1 XBIT | 2.062 EUR |
| 5 XBIT | 10.31 EUR |
| 10 XBIT | 20.62 EUR |
| |
|---|---|
| 0.5 EUR | 0.24247 XBIT |
| 1 EUR | 0.48495 XBIT |
| 5 EUR | 2.424 XBIT |
| 10 EUR | 4.849 XBIT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
XBIT is trading at €2.062, -1.23% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XBIT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XBIT is currently trading at €2.062, -1.23% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XBIT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XBIT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XBIT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XBIT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
XBiotech Inc's market cap is currently 62.61M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume19.09K
24h highest2.1300 EUR
24h lowest2.0672 EUR
24h Price movement-1.23%
Start trade with XBIT Perpetual
Sign up to trade